{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:04Z","timestamp":1791231544960,"version":"4.1.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Embolic stroke of unknown source (ESUS) represents one in five ischemic strokes. Ipsilateral non-stenotic carotid plaques are identified in 40% of all ESUS. In this narrative review, we summarize the evidence supporting the potential causal relationship between ESUS and non-stenotic carotid plaques; discuss the remaining challenges in establishing the causal link between non-stenotic plaques and ESUS and describe biomarkers of potential interest for future research. In support of the causal relationship between ESUS and non-stenotic carotid plaques, studies have shown that plaques with high-risk features are five times more prevalent in the ipsilateral vs. the contralateral carotid and there is a lower incidence of atrial fibrillation during follow-up in patients with ipsilateral non-stenotic carotid plaques. However, non-stenotic carotid plaques with or without high-risk features often coexist with other potential etiologies of stroke, notably atrial fibrillation (8.5%), intracranial atherosclerosis (8.4%), patent foramen ovale (5\u20139%), and atrial cardiopathy (2.4%). Such puzzling clinical associations make it challenging to confirm the causal link between non-stenotic plaques and ESUS. There are several ongoing studies exploring whether select protein and RNA biomarkers of plaque progression or vulnerability could facilitate the reclassification of some ESUS as large vessel strokes or help to optimize secondary prevention strategies.<\/jats:p>","DOI":"10.3389\/fneur.2021.719329","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T05:24:19Z","timestamp":1632288259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Non-stenotic Carotid Plaques in Embolic Stroke of Unknown Source"],"prefix":"10.3389","volume":"12","author":[{"given":"Joseph","family":"Kamtchum-Tatuene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Z.","family":"Nomani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Falcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Munsterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twinkle","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen C.","family":"Jickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1756286419851381","DOI":"10.1177\/1756286419851381","article-title":"Embolic strokes of undetermined source: theoretical construct or useful clinical tool?","volume":"12","author":"Tsivgoulis","year":"2019","journal-title":"Ther Adv Neurol Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2019.11.024","article-title":"Embolic stroke of undetermined source: JACC review topic of the week","volume":"75","author":"Ntaios","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/14779072.2017.1355238","article-title":"Atrial cardiopathy: a mechanism of cryptogenic stroke","volume":"15","author":"Yaghi","year":"2017","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/STROKEAHA.119.027272","article-title":"carotid plaque with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis","volume":"51","author":"Kamtchum-Tatuene","year":"2020","journal-title":"Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jacc.2020.12.015","article-title":"Intracranial atherosclerotic plaque as a potential cause of embolic stroke of undetermined source","volume":"77","author":"Tao","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2644","DOI":"10.1212\/WNL.0000000000007611","article-title":"Carotid plaques and detection of atrial fibrillation in embolic stroke of undetermined source","volume":"92","author":"Ntaios","year":"2019","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1161\/STROKEAHA.119.025168","article-title":"Efficacy and safety of rivaroxaban versus aspirin in embolic stroke of undetermined source and carotid atherosclerosis","volume":"50","author":"Ntaios","year":"2019","journal-title":"Stroke."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1161\/STROKEAHA.120.029404","article-title":"Prevalence of ipsilateral nonstenotic carotid plaques on computed tomography angiography in embolic stroke of undetermined source","volume":"51","author":"Ospel","year":"2020","journal-title":"Stroke."},{"key":"B18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0000000000002978","article-title":"Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke","volume":"87","author":"Coutinho","year":"2016","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2658","article-title":"Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis","volume":"77","author":"Kamtchum-Tatuene","year":"2020","journal-title":"JAMA Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jcmg.2019.03.028","article-title":"Prediction of stroke risk by detection of hemorrhage in carotid plaques: meta-analysis of individual patient data","volume":"13","author":"Schindler","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(19)30035-3","article-title":"Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications","volume":"18","author":"Saba","year":"2019","journal-title":"Lancet Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jacc.2021.01.038","article-title":"Atherosclerotic carotid plaque composition and incident stroke and coronary events","volume":"77","author":"Bos","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/STROKEAHA.119.027268","article-title":"A risk score including carotid plaque inflammation and stenosis severity improves identification of recurrent stroke","volume":"51","author":"Kelly","year":"2020","journal-title":"Stroke."},{"key":"B24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nic.2021.02.002","article-title":"Extracranial vascular disease: carotid stenosis and plaque imaging","volume":"31","author":"Baradaran","year":"2021","journal-title":"Neuroimaging Clin N Am."},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nic.2015.09.008","article-title":"Detection of vulnerable plaque in patients with cryptogenic stroke","volume":"26","author":"Bayer-Karpinska","year":"2016","journal-title":"Neuroimaging Clin N Am."},{"key":"B26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1212\/WNL.0000000000009480","article-title":"Imaging of the vulnerable carotid plaque: role of imaging techniques and a research agenda","volume":"94","author":"Fabiani","year":"2020","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/svn-2017-000129","article-title":"How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting","volume":"3","author":"Paraskevas","year":"2018","journal-title":"Stroke Vasc Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/01.STR.29.3.725","article-title":"Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection","volume":"29","author":"Ringelstein","year":"1998","journal-title":"Stroke."},{"key":"B29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/01.ATV.0000149867.61851.31","article-title":"Quantitative evaluation of carotid plaque composition by in vivo MRI","volume":"25","author":"Saam","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/01.STR.23.5.668","article-title":"Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus","volume":"23","author":"Markus","year":"1992","journal-title":"Stroke."},{"key":"B31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.21037\/cdt.2020.01.08","article-title":"Contrast imaging ultrasound for the detection and characterization of carotid vulnerable plaque","volume":"10","author":"Rafailidis","year":"2020","journal-title":"Cardiovasc Diagn Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","article-title":"Natural history and histological classification of atherosclerotic lesions: an update","volume":"20","author":"Stary","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7223","article-title":"Roadmap consensus on carotid artery plaque imaging and impact on therapy strategies and guidelines: an international, multispecialty, expert review and position statement","author":"Saba","year":"2021","journal-title":"AJNR Am J Neuroradiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2377-13-201","article-title":"The carotid plaque imaging in acute stroke (CAPIAS) study: protocol and initial baseline data","volume":"13","author":"Bayer-Karpinska","year":"2013","journal-title":"BMC Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jcmg.2012.01.012","article-title":"Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke","volume":"5","author":"Freilinger","year":"2012","journal-title":"JACC Cardiovasc Imaging."},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00259-015-3201-8","article-title":"High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET\/MR imaging","volume":"43","author":"Hyafil","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.043","article-title":"Carotid ultrasound for assessment of nonobstructive carotid atherosclerosis in young adults with cryptogenic stroke","volume":"27","author":"Buon","year":"2018","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2020.09.532","article-title":"Complicated carotid artery plaques as a cause of cryptogenic stroke","volume":"76","author":"Kopczak","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jcmg.2012.03.014","article-title":"Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study","volume":"5","author":"Sun","year":"2012","journal-title":"JACC Cardiovasc Imaging."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1161\/STROKEAHA.120.030537","article-title":"Nonstenotic carotid plaque in embolic stroke of undetermined source: interplay of arterial and atrial disease","volume":"51","author":"Grosse","year":"2020","journal-title":"Stroke."},{"key":"B42","doi-asserted-by":"publisher","first-page":"104936","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104936","article-title":"Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: recurrent stroke risk and response to antithrombotic therapy","volume":"29","author":"Ameriso","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"105409","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105409","article-title":"Carotid atherosclerosis and patent foramen ovale in embolic stroke of undetermined source","volume":"30","author":"Ntaios","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ene.13275","article-title":"Non-obstructive carotid atherosclerosis and patent foramen ovale in young adults with cryptogenic stroke","volume":"24","author":"Jaffre","year":"2017","journal-title":"Eur J Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/STROKEAHA.119.028154","article-title":"Atrial cardiopathy and nonstenosing large artery plaque in patients with embolic stroke of undetermined source","volume":"51","author":"Kamel","year":"2020","journal-title":"Stroke."},{"key":"B46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of LOX-1 (Lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e013803","DOI":"10.1161\/JAHA.119.013803","article-title":"Soluble LOX-1: a novel biomarker in patients with coronary artery disease, stroke, and acute aortic dissection?","volume":"9","author":"Hofmann","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e009874","DOI":"10.1161\/JAHA.118.009874","article-title":"High levels of soluble lectinlike oxidized low-density lipoprotein receptor-1 are associated with carotid plaque inflammation and increased risk of ischemic stroke","volume":"8","author":"Markstad","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.5551\/jat.32466","article-title":"High levels of soluble lectin-like oxidized low-density lipoprotein receptor-1 in acute stroke: an age- and sex-matched cross-sectional study","volume":"23","author":"Yokota","year":"2016","journal-title":"J Atheroscler Thromb."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e00879","DOI":"10.1002\/brb3.879","article-title":"Role of sLOX-1 in intracranial artery stenosis and in predicting long-term prognosis of acute ischemic stroke","volume":"8","author":"Li","year":"2018","journal-title":"Brain Behav."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/ene.13973","article-title":"Association between non-high-density lipoprotein cholesterol levels and asymptomatic vulnerable carotid atherosclerotic plaques","volume":"26","author":"Wu","year":"2019","journal-title":"Eur J Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e83393","DOI":"10.1371\/journal.pone.0083393","article-title":"Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study","volume":"9","author":"Katan","year":"2014","journal-title":"PLoS ONE."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1212\/WNL.0000000000008733","article-title":"Lp-PLA2 and dual antiplatelet agents in intracranial arterial stenosis","volume":"94","author":"Yang","year":"2019","journal-title":"Neurology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12017-019-08530-0","article-title":"Blood biomarkers for stroke diagnosis and management","volume":"21","author":"Kamtchum-Tatuene","year":"2019","journal-title":"Neuromolecular Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"622869","DOI":"10.3389\/fneur.2021.622869","article-title":"YKL-40 is associated with ultrasound-determined carotid atherosclerotic plaque instability","volume":"12","author":"Wang","year":"2021","journal-title":"Front Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/j.atherosclerosis.2007.05.001","article-title":"Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity","volume":"195","author":"Skjelland","year":"2007","journal-title":"Atherosclerosis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.atherosclerosis.2009.05.003","article-title":"Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis","volume":"207","author":"Nasr","year":"2009","journal-title":"Atherosclerosis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12872-020-01709-5","article-title":"Early identification of carotid vulnerable plaque in asymptomatic patients","volume":"20","author":"Jiao","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1161\/STROKEAHA.108.517128","article-title":"Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability","volume":"39","author":"Handberg","year":"2008","journal-title":"Stroke."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/ATVBAHA.121.316091","article-title":"Monocyte-chemoattractant protein-1 levels in human atherosclerotic lesions associate with plaque vulnerability","volume":"1","author":"Georgakis","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/STROKEAHA.116.013650","article-title":"Circulating microRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis","volume":"48","author":"Dolz","year":"2017","journal-title":"Stroke."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.009","article-title":"The relevance of vascular endothelial growth factor, hypoxia inducible factor-1 alpha, and clusterin in carotid plaque instability","volume":"28","author":"Basic","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"718329","DOI":"10.1155\/2015\/718329","article-title":"Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis","volume":"2015","author":"Ammirati","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/STROKEAHA.120.032111","article-title":"Circulating vimentin is associated with future incidence of stroke in a population-based cohort study","volume":"52","author":"Xiao","year":"2021","journal-title":"Stroke."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/ene.14806","article-title":"Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase-9 level and susceptibility vessel sign length","volume":"28","author":"Alhazmi","year":"2021","journal-title":"Eur J Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ana.22187","article-title":"Signatures of cardioembolic and large-vessel ischemic stroke","volume":"68","author":"Jickling","year":"2010","journal-title":"Ann Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/STROKEAHA.120.033217","article-title":"d-dimer level as a predictor of recurrent stroke in patients with embolic stroke of undetermined source","volume":"52","author":"Choi","year":"2021","journal-title":"Stroke."},{"key":"B69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5551\/jat.42135","article-title":"Omentin-1 is associated with carotid plaque instability among ischemic stroke patients","volume":"25","author":"Xu","year":"2018","journal-title":"J Atheroscler Thromb."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1161\/STROKEAHA.120.030228","article-title":"Expression of Resistin, Chemerin, and Chemerin's receptor in the unstable carotid atherosclerotic plaque","volume":"52","author":"Yanofsky","year":"2021","journal-title":"Stroke."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.02.005","article-title":"Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: the Tromso Study","volume":"271","author":"Eltoft","year":"2018","journal-title":"Atherosclerosis."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab231","article-title":"From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?","author":"Ridker","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","article-title":"LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation","volume":"69","author":"Pothineni","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12975-018-0658-3","article-title":"Complement complex C5b-9 levels are associated with the clinical outcomes of acute ischemic stroke and carotid plaque stability","volume":"10","author":"Si","year":"2018","journal-title":"Transl Stroke Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","article-title":"Expression of the NLRP3 inflammasome in carotid atherosclerosis","volume":"24","author":"Shi","year":"2015","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jvs.2007.11.066","article-title":"A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis","volume":"47","author":"Arthurs","year":"2008","journal-title":"J Vasc Surg."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/ATVBAHA.108.169292","article-title":"Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area","volume":"28","author":"Klein","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"100382","DOI":"10.1016\/j.ijcha.2019.100382","article-title":"Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: an optical coherence tomography study","volume":"24","author":"Muramatsu","year":"2019","journal-title":"Int J Cardiol Heart Vasc."},{"key":"B81","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/07853890.2020.1775287","article-title":"Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options","volume":"52","author":"Rehberger","year":"2020","journal-title":"Ann Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/STROKEAHA.120.032964","article-title":"carotid plaques from symptomatic patients are characterized by local increase in xanthine oxidase expression","volume":"52","author":"Ganji","year":"2021","journal-title":"Stroke."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"Stability","year":"2014","journal-title":"N Engl J Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: a phase I trial","volume":"11","author":"Pires","year":"2020","journal-title":"J Ayurveda Integr Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1182\/blood-2014-02-555805","article-title":"New anti-complement drugs: not so far away","volume":"123","author":"Thurman","year":"2014","journal-title":"Blood."},{"key":"B86","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.119.045256","article-title":"From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents?","volume":"141","author":"Ridker","year":"2020","journal-title":"Circulation."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1161\/STROKEAHA.120.032698","article-title":"Letter by Kamtchum-Tatuene and Jickling Regarding Article, \u201cElevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy\u201d","volume":"52","author":"Kamtchum-Tatuene","year":"2021","journal-title":"Stroke."},{"key":"B91","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents","volume":"124","author":"Hegele","year":"2019","journal-title":"Circ Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMra1806939","article-title":"Lipid management for the prevention of atherosclerotic cardiovascular disease","volume":"381","author":"Michos","year":"2019","journal-title":"N Engl J Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1042\/CS20180684","article-title":"Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker","volume":"132","author":"Magenta","year":"2018","journal-title":"Clin Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/2396987317703210","article-title":"Searching for explanations for cryptogenic stroke in the young: revealing the triggers, causes, and outcome (SECRETO): rationale and design","volume":"2","author":"Putaala","year":"2017","journal-title":"Eur Stroke J."},{"key":"B96","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12975-017-0537-3","article-title":"Biomarkers of Acute Stroke Etiology (BASE) study methodology","volume":"8","author":"Jauch","year":"2017","journal-title":"Transl Stroke Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"104604","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104604","article-title":"increased left atrial appendage density on computerized tomography is associated with cardioembolic stroke","volume":"29","author":"Chang","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.01.028","article-title":"A simple score that predicts paroxysmal atrial fibrillation on outpatient cardiac monitoring after embolic stroke of unknown source","volume":"27","author":"Ricci","year":"2018","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/STROKEAHA.119.027990","article-title":"External performance of the HAVOC score for the prediction of new incident atrial fibrillation","volume":"51","author":"Ntaios","year":"2020","journal-title":"Stroke."},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1747493020925281","article-title":"Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: the AF-ESUS score","volume":"16","author":"Ntaios","year":"2021","journal-title":"Int J Stroke."},{"key":"B101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods","volume":"14","author":"Kamel","year":"2018","journal-title":"Int J Stroke."},{"key":"B102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/svn-2020-000440","article-title":"Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies","volume":"6","author":"Zhang","year":"2020","journal-title":"Stroke Vasc Neurol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1161\/STROKEAHA.119.028853","article-title":"Embolic stroke of undetermined source and symptomatic nonstenotic carotid disease","volume":"51","author":"Goyal","year":"2020","journal-title":"Stroke."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/STROKEAHA.120.032453","article-title":"Embolic stroke of undetermined source and patent foramen ovale: risk of paradoxical embolism score validation and atrial fibrillation prediction","volume":"52","author":"Strambo","year":"2021","journal-title":"Stroke."},{"key":"B105","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/STROKEAHA.117.017895","article-title":"antiplatelet regimen for patients with breakthrough strokes while on aspirin: a systematic review and meta-analysis","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","article-title":"Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trials","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11239-011-0667-5","article-title":"P2Y12 platelet inhibition in clinical practice","volume":"33","author":"Damman","year":"2012","journal-title":"J Thromb Thrombolysis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation."},{"key":"B111","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/STROKEAHA.120.033040","article-title":"P2Y12 inhibitors plus aspirin versus aspirin alone in patients with minor stroke or high-risk transient ischemic attack","volume":"52","author":"Li","year":"2021","journal-title":"Stroke."},{"key":"B113","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/svn-2020-000791","article-title":"Clopidogrel with aspirin in high-risk patients with acute non-disabling cerebrovascular events II (CHANCE-2): rationale and design of a multicentre randomised trial","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1161\/STROKEAHA.120.031763","article-title":"Antiplatelet therapy for transient ischemic attack and minor stroke","volume":"51","author":"Xiong","year":"2020","journal-title":"Stroke."},{"key":"B115","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.ijcha.2021.100780","article-title":"Rhythm monitoring strategies for atrial fibrillation detection in patients with cryptogenic stroke: a systematic review and meta-analysis","volume":"34","author":"Noubiap","year":"2021","journal-title":"Int J Cardiol Heart Vasc."},{"key":"B116","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamaneurol.2019.2984","article-title":"Association between low-dose rivaroxaban with or without aspirin and ischemic stroke subtypes: a secondary analysis of the COMPASS trial","volume":"77","author":"Perera","year":"2020","journal-title":"JAMA Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/CIRCULATIONAHA.118.035864","article-title":"Stroke outcomes in the COMPASS trial","volume":"139","author":"Sharma","year":"2019","journal-title":"Circulation."},{"key":"B118","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","article-title":"Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE esus randomized clinical trial","volume":"76","author":"Healey","year":"2019","journal-title":"JAMA Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(18)30167-4","article-title":"Oxford vascular study phenotyped C. prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis","volume":"17","author":"Mazzucco","year":"2018","journal-title":"Lancet Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jamaneurol.2020.1948","article-title":"Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review","volume":"77","author":"Mazzucco","year":"2020","journal-title":"JAMA Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.09.001","article-title":"Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study","volume":"25","author":"Yaghi","year":"2016","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke."},{"key":"B123","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1161\/STROKEAHA.120.030730","article-title":"Rationale, design, and implementation of intensive risk factor treatment in the CREST2 trial","volume":"51","author":"Turan","year":"2020","journal-title":"Stroke."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/eurheartj\/ehz629","article-title":"Don't stop the statin!","volume":"40","author":"Cannon","year":"2019","journal-title":"Eur Heart J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(20)32333-3","article-title":"Never too old to benefit from lipid-lowering treatment","volume":"396","author":"Raal","year":"2020","journal-title":"Lancet."},{"key":"B127","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(18)32263-3","article-title":"Never too old for statin treatment?","volume":"393","author":"Cheung","year":"2019","journal-title":"Lancet."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1161\/STROKEAHA.120.030089","article-title":"Deintensification or no statin treatment is associated with higher mortality in patients with ischemic stroke or transient ischemic attack","volume":"52","author":"Dearborn-Tomazos","year":"2021","journal-title":"Stroke."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","article-title":"Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"39","author":"Sillesen","year":"2008","journal-title":"Stroke."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11789-019-00099-z","article-title":"Lipoprotein(a) and proprotein convertase subtilisin\/kexin type 9 inhibitors","volume":"14","author":"Julius","year":"2019","journal-title":"Clin Res Cardiol Suppl."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","article-title":"Evinacumab in patients with refractory hypercholesterolemia","volume":"383","author":"Rosenson","year":"2020","journal-title":"N Engl J Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"104653","DOI":"10.1016\/j.phrs.2020.104653","article-title":"Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia","volume":"153","author":"Ruscica","year":"2020","journal-title":"Pharmacol Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"e016262","DOI":"10.1161\/JAHA.119.016262","article-title":"Efficacy and safety of Bempedoic acid in patients with hypercholesterolemia: systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Di Minno","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B136","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40265-018-0870-1","article-title":"Effect of ezetimibe monotherapy on plasma Lipoprotein(a) concentrations in patients with primary hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials","volume":"78","author":"Awad","year":"2018","journal-title":"Drugs."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur Heart J."},{"key":"B138","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2016.08.013","article-title":"Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults","volume":"253","author":"Beheshtian","year":"2016","journal-title":"Atherosclerosis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/j.jcjo.2018.07.011","article-title":"Elevated lipoprotein(a) levels as the cause of cryptogenic stroke in a young Ashkenazi Jewish female","volume":"54","author":"Lin","year":"2019","journal-title":"Can J Ophthalmol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrneurol.2016.125","article-title":"Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke","volume":"12","author":"Esenwa","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jamacardio.2020.2413","article-title":"Effect of C-reactive protein on Lipoprotein(a)-associated cardiovascular risk in optimally treated patients with high-risk vascular disease: a prespecified secondary analysis of the ACCELERATE trial","volume":"5","author":"Puri","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2010.11.005","article-title":"2011 ASA\/ACCF\/AHA\/AANN\/AANS\/ACR\/ASNR\/CNS\/SAIP\/SCAI\/SIR\/SNIS\/SVM\/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery","volume":"57","author":"Brott","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor's Choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Naylor","year":"2018","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B146","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873211026990","article-title":"European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis","volume":"6","author":"Bonati","year":"2021","journal-title":"Eur Stroke J."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/ene.14198","article-title":"Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis","volume":"27","author":"Katsanos","year":"2020","journal-title":"Eur J Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline From the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke."},{"key":"B149","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1559827618812395","article-title":"Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe","year":"2019","journal-title":"Am J Lifestyle Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41569-021-00532-5","article-title":"Transportation noise pollution and cardiovascular disease","volume":"18","author":"Munzel","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/eurheartj\/ehw294","article-title":"Environmental stressors and cardio-metabolic disease: part II-mechanistic insights","volume":"38","author":"Munzel","year":"2017","journal-title":"Eur Heart J."},{"key":"B152","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/eurheartj\/ehw269","article-title":"Environmental stressors and cardio-metabolic disease: part I-epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies","volume":"38","author":"Munzel","year":"2017","journal-title":"Eur Heart J."},{"key":"B153","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-019-0948-2","article-title":"Sleep modulates haematopoiesis and protects against atherosclerosis","volume":"566","author":"McAlpine","year":"2019","journal-title":"Nature."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1212\/WNL.0000000000001371","article-title":"Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis","volume":"84","author":"Leng","year":"2015","journal-title":"Neurology."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.719329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T05:24:24Z","timestamp":1632288264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.719329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":155,"alternative-id":["10.3389\/fneur.2021.719329"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.719329","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"article-number":"719329"}}